Ikarian Capital, LLC Genocea Biosciences, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.01 - $1.38 $2,063 - $284,743	-206,336 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.96 - $1.35 $9,134 - $12,845	9,515 Added 4.83%	206,336 $259,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.33 $5,531 - $7,407	-3,179 Reduced 1.59%	196,821 $377,000
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $249,739 - $341,877	121,233 Added 153.91%	200,000 $468,000
Q1 2021 May 17, 2021	BUY	$2.35 - $4.01 $185,102 - $315,855	78,767 New	78,767 $213,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.